Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.

Cobo Dols M, Beato Zambrano C, Cabezón Gutiérrez L, Chicas Sett R, Blancas López-Barajas MI, García Navalón F, Fírvida Pérez JL, Serrano Bermúdez G, Togores Torres P, Delgado Mingorance I, Giraldo Marín A, Librán Oriol A, Paredes Lario A, Sánchez Mauriño P, Higuera Gómez O, Moreno Muñoz D, Jiménez López AJ, Huerta González I, Sanz Yagüe A, Soler López B

Open source

DOI
10.1136/bmjspcare-2020-002249
Published
2021 Mar
Container
BMJ supportive & palliative care
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjspcare-2020-002249,
  title = {Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.},
  author = {Cobo Dols M and Beato Zambrano C and Cabezón Gutiérrez L and Chicas Sett R and Blancas López-Barajas MI and García Navalón F and Fírvida Pérez JL and Serrano Bermúdez G and Togores Torres P and Delgado Mingorance I and Giraldo Marín A and Librán Oriol A and Paredes Lario A and Sánchez Mauriño P and Higuera Gómez O and Moreno Muñoz D and Jiménez López AJ and Huerta González I and Sanz Yagüe A and Soler López B},
  year = {2021},
  journal = {BMJ supportive \& palliative care},
  doi = {10.1136/bmjspcare-2020-002249},
  url = {https://doi.org/10.1136/bmjspcare-2020-002249}
}

RIS

TY  - JOUR
TI  - Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
AU  - Cobo Dols M
AU  - Beato Zambrano C
AU  - Cabezón Gutiérrez L
AU  - Chicas Sett R
AU  - Blancas López-Barajas MI
AU  - García Navalón F
AU  - Fírvida Pérez JL
AU  - Serrano Bermúdez G
AU  - Togores Torres P
AU  - Delgado Mingorance I
AU  - Giraldo Marín A
AU  - Librán Oriol A
AU  - Paredes Lario A
AU  - Sánchez Mauriño P
AU  - Higuera Gómez O
AU  - Moreno Muñoz D
AU  - Jiménez López AJ
AU  - Huerta González I
AU  - Sanz Yagüe A
AU  - Soler López B
PY  - 2021
JO  - BMJ supportive & palliative care
DO  - 10.1136/bmjspcare-2020-002249
UR  - https://doi.org/10.1136/bmjspcare-2020-002249
ER  - 

APA

M, C. D., C, B. Z., L, C. G., R, C. S., MI, B. L., F, G. N., JL, F. P., G, S. B., P, T. T., I, D. M., A, G. M., A, L. O., A, P. L., P, S. M., O, H. G., D, M. M., AJ, J. L., I, H. G., A, S. Y., & B, S. L. (2021). Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.. BMJ supportive & palliative care. https://doi.org/10.1136/bmjspcare-2020-002249

Source records